Centiva Capital, LP Haemonetics Corp Transaction History

Centiva Capital, LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$81.24 - $97.37 $370,210 - $443,715	4,557 New	4,557 $377,000
Q2 2023 Aug 14, 2023	BUY	$80.84 - $89.45 $469,680 - $519,704	5,810 New	5,810 $494,000
Q4 2022 Feb 14, 2023	SELL	$73.85 - $86.14 $148,290 - $172,969	-2,008 Reduced 30.48%	4,581 $360,000
Q3 2022 Nov 14, 2022	BUY	$63.3 - $78.66 $417,083 - $518,290	6,589 New	6,589 $488,000
Q2 2022 Aug 15, 2022	BUY	$49.27 - $66.08 $246,350 - $330,400	5,000 New	5,000 $326,000
Q1 2022 May 16, 2022	SELL	$43.77 - $63.22 $353,661 - $510,817	-8,080 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$49.55 - $74.59 $400,364 - $602,687	8,080 New	8,080 $429,000
Q3 2021 Nov 15, 2021	SELL	$57.6 - $70.59 $1.09 Million - $1.33 Million	-18,889 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$51.81 - $118.56 $739,173 - $1.69 Million	14,267 Added 308.68%	18,889 $1.26 Million
Q1 2021 May 17, 2021	BUY	$111.01 - $139.48 $513,088 - $644,676	4,622 New	4,622 $513,000

333

54M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.21B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Centiva Capital, LP with notifications on news.